Skip to main content
Top
Published in:

03-01-2024 | Acute Kidney Injury | Original Research Article

Antibiotic-Associated Acute Kidney Injury Among Older Adults: A Case-Crossover Study

Authors: Tichawona Chinzowu, Te-yuan Chyou, Prasad S. Nishtala

Published in: Clinical Drug Investigation | Issue 2/2024

Login to get access

Abstract

Background and objectives

Drug-related acute kidney injury is quite common in older adults. The associated drugs, including antibiotics, are often co-prescribed. The objective of this study was to ascertain antibiotic-associated acute kidney injury (AKI) in older adults aged 65 years or above in New Zealand using a case-crossover study design.

Methods

The International Statistical Classification of Diseases and Related Health Problems, tenth revision, Australian modification code N17.x was used to identify all individuals aged 65 years and above with a diagnosis of incident AKI on admission between 1 January 2005 and 31 December 2020, from the New Zealand National Minimum Data Set. A case-crossover cohort for antibiotic exposures, with a 3 day case period and two 30 day washout periods, summed up to a 66 day study period, was created. Using conditional logistic regression, the changed odds of AKI due to exposure to an antibiotic was calculated as matched odds ratios and their 95% confidence intervals.

Results

A total of 2399 incident cases of AKI were identified between 2005 and 2020 among older adults. The adjusted odds of consuming sulfamethoxazole/trimethoprim antibiotic during the case period was 3.57 times (95% CI 2.86–4.46) higher than the reference period among the incident AKI cases. Fluoroquinolone utilization was also associated with incident AKI (adjusted OR = 2.56; 95% CI 1.90–3.46).

Conclusion

The potential of sulfamethoxazole/trimethoprim and fluoroquinolones to be associated with AKI raises the significant need for vigilant prescribing of these antibiotics in older adults.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vamvakas S. EU Perspective on ICH. Global Approach in Safety Testing. Springer; 2013. p. 13–21.CrossRef Vamvakas S. EU Perspective on ICH. Global Approach in Safety Testing. Springer; 2013. p. 13–21.CrossRef
2.
go back to reference Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol. 2006;17(4):1135–42.PubMedCrossRef Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol. 2006;17(4):1135–42.PubMedCrossRef
3.
go back to reference Kerr M, Bedford M, Matthews B, O’Donoghue D. The economic impact of acute kidney injury in England. Nephrol Dial Transplant. 2014;29(7):1362–8.PubMedCrossRef Kerr M, Bedford M, Matthews B, O’Donoghue D. The economic impact of acute kidney injury in England. Nephrol Dial Transplant. 2014;29(7):1362–8.PubMedCrossRef
4.
go back to reference Silver SA, Chertow GM. The economic consequences of acute kidney injury. Nephron. 2017;137(4):297–301.PubMedCrossRef Silver SA, Chertow GM. The economic consequences of acute kidney injury. Nephron. 2017;137(4):297–301.PubMedCrossRef
5.
6.
go back to reference Yokota LG, Sampaio BM, Rocha EP, Balbi AL, Sousa Prado IR, Ponce D. Acute kidney injury in elderly patients: narrative review on incidence, risk factors, and mortality. Int J Nephrol Renovasc Dis. 2018;11:217–24.PubMedPubMedCentralCrossRef Yokota LG, Sampaio BM, Rocha EP, Balbi AL, Sousa Prado IR, Ponce D. Acute kidney injury in elderly patients: narrative review on incidence, risk factors, and mortality. Int J Nephrol Renovasc Dis. 2018;11:217–24.PubMedPubMedCentralCrossRef
7.
go back to reference Anderson S, Eldadah B, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, et al. Acute kidney injury in older adults. J Am Soc Nephrol. 2011;22(1):28–38.PubMedCrossRef Anderson S, Eldadah B, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, et al. Acute kidney injury in older adults. J Am Soc Nephrol. 2011;22(1):28–38.PubMedCrossRef
8.
go back to reference Mohsen S, Dickinson JA, Somayaji R. Update on the adverse effects of antimicrobial therapies in community practice. Can Fam Physician. 2020;66(9):651–9.PubMedPubMedCentral Mohsen S, Dickinson JA, Somayaji R. Update on the adverse effects of antimicrobial therapies in community practice. Can Fam Physician. 2020;66(9):651–9.PubMedPubMedCentral
9.
go back to reference Chinzowu T, Roy S, Nishtala PS. Risk of antimicrobial-associated organ injury among the older adults: a systematic review and meta-analysis. BMC Geriatr. 2021;21(1):617.PubMedPubMedCentralCrossRef Chinzowu T, Roy S, Nishtala PS. Risk of antimicrobial-associated organ injury among the older adults: a systematic review and meta-analysis. BMC Geriatr. 2021;21(1):617.PubMedPubMedCentralCrossRef
10.
go back to reference Gbinigie O. Trimethoprim is associated with a greater risk of acute kidney injury and hyperkalaemia in older adults compared with other antibiotics used to treat UTIs. BMJ Evid Based Med. 2018;23(6):233–4.PubMedPubMedCentralCrossRef Gbinigie O. Trimethoprim is associated with a greater risk of acute kidney injury and hyperkalaemia in older adults compared with other antibiotics used to treat UTIs. BMJ Evid Based Med. 2018;23(6):233–4.PubMedPubMedCentralCrossRef
11.
go back to reference Chinzowu T, Chyou TY, Nishtala PS. Antibacterial-associated acute kidney injury among older adults: a post-marketing surveillance study using the FDA adverse events reporting system. Pharmacoepidemiol Drug Saf. 2022;31:1190–8.PubMedPubMedCentralCrossRef Chinzowu T, Chyou TY, Nishtala PS. Antibacterial-associated acute kidney injury among older adults: a post-marketing surveillance study using the FDA adverse events reporting system. Pharmacoepidemiol Drug Saf. 2022;31:1190–8.PubMedPubMedCentralCrossRef
13.
go back to reference Consiglio GP, Burden AM, Maclure M, McCarthy L, Cadarette SM. Case-crossover study design in pharmacoepidemiology: systematic review and recommendations. Pharmacoepidemiol Drug Saf. 2013;22(11):1146–53.PubMedCrossRef Consiglio GP, Burden AM, Maclure M, McCarthy L, Cadarette SM. Case-crossover study design in pharmacoepidemiology: systematic review and recommendations. Pharmacoepidemiol Drug Saf. 2013;22(11):1146–53.PubMedCrossRef
14.
go back to reference Jaakkola J. Case-crossover design in air pollution epidemiology. Eur Respir J. 2003;21(40 suppl):81s-s85.CrossRef Jaakkola J. Case-crossover design in air pollution epidemiology. Eur Respir J. 2003;21(40 suppl):81s-s85.CrossRef
15.
go back to reference Valent F, Brusaferro S, Barbone F. A case-crossover study of sleep and childhood injury. Pediatrics. 2001;107(2):e-23-e.CrossRef Valent F, Brusaferro S, Barbone F. A case-crossover study of sleep and childhood injury. Pediatrics. 2001;107(2):e-23-e.CrossRef
16.
go back to reference McEvoy SP, Stevenson MR, McCartt AT, Woodward M, Haworth C, Palamara P, et al. Role of mobile phones in motor vehicle crashes resulting in hospital attendance: a case-crossover study. BMJ. 2005;331(7514):428.PubMedPubMedCentralCrossRef McEvoy SP, Stevenson MR, McCartt AT, Woodward M, Haworth C, Palamara P, et al. Role of mobile phones in motor vehicle crashes resulting in hospital attendance: a case-crossover study. BMJ. 2005;331(7514):428.PubMedPubMedCentralCrossRef
17.
go back to reference Nishtala PS, Chyou TY, Held F, Le Couteur DG, Gnjidic D. Association rules method and big data: evaluating frequent medication combinations associated with fractures in older adults. Pharmacoepidemiol Drug Saf. 2018;27(10):1123–30.PubMedCrossRef Nishtala PS, Chyou TY, Held F, Le Couteur DG, Gnjidic D. Association rules method and big data: evaluating frequent medication combinations associated with fractures in older adults. Pharmacoepidemiol Drug Saf. 2018;27(10):1123–30.PubMedCrossRef
18.
go back to reference Nishtala PS, Chyou TY. Identifying drug combinations associated with acute kidney injury using association rules method. Pharmacoepidemiol Drug Saf. 2020;29(4):467–73.PubMedCrossRef Nishtala PS, Chyou TY. Identifying drug combinations associated with acute kidney injury using association rules method. Pharmacoepidemiol Drug Saf. 2020;29(4):467–73.PubMedCrossRef
19.
go back to reference Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991;133(2):144–53.PubMedCrossRef Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991;133(2):144–53.PubMedCrossRef
20.
go back to reference Maclure M, Mittleman MA. Should we use a case-crossover design? Annu Rev Public Health. 2000;21:193–221.PubMedCrossRef Maclure M, Mittleman MA. Should we use a case-crossover design? Annu Rev Public Health. 2000;21:193–221.PubMedCrossRef
21.
go back to reference Hebert C, Delaney J, Hemmelgarn B, Lévesque LE, Suissa S. Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs. Pharmacoepidemiol Drug Saf. 2007;16(8):845–9.PubMedCrossRef Hebert C, Delaney J, Hemmelgarn B, Lévesque LE, Suissa S. Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs. Pharmacoepidemiol Drug Saf. 2007;16(8):845–9.PubMedCrossRef
23.
go back to reference Xu L, Wu Y, Chen Y, Li R, Wang Z, Li Z, et al. Is acute kidney injury age-dependent in older adults: an observational study in two centers from North China. BMC Geriatr. 2021;21(1):7.ADSPubMedPubMedCentralCrossRef Xu L, Wu Y, Chen Y, Li R, Wang Z, Li Z, et al. Is acute kidney injury age-dependent in older adults: an observational study in two centers from North China. BMC Geriatr. 2021;21(1):7.ADSPubMedPubMedCentralCrossRef
24.
go back to reference He W, Liu X, Hu B, Li D, Chen L, Li Y, et al. Gender and ethnic disparities of acute kidney injury in COVID-19 infected patients: a literature review. Front Cell Infect Microbiol. 2021;11: 778636.PubMedCrossRef He W, Liu X, Hu B, Li D, Chen L, Li Y, et al. Gender and ethnic disparities of acute kidney injury in COVID-19 infected patients: a literature review. Front Cell Infect Microbiol. 2021;11: 778636.PubMedCrossRef
25.
go back to reference Chew ST, Mar WM, Ti LK. Association of ethnicity and acute kidney injury after cardiac surgery in a South East Asian population. Br J Anaesth. 2013;110(3):397–401.PubMedCrossRef Chew ST, Mar WM, Ti LK. Association of ethnicity and acute kidney injury after cardiac surgery in a South East Asian population. Br J Anaesth. 2013;110(3):397–401.PubMedCrossRef
26.
go back to reference Khruleva Y, Mubayazvamba T, Troitskaya E, Efremovtseva M, Kobalava Z. Hypertension is a risk factor for acute kidney injury and a predictor of mortality in hospitalized patients with COVID-19. J Hypertens. 2021;39: e406.CrossRef Khruleva Y, Mubayazvamba T, Troitskaya E, Efremovtseva M, Kobalava Z. Hypertension is a risk factor for acute kidney injury and a predictor of mortality in hospitalized patients with COVID-19. J Hypertens. 2021;39: e406.CrossRef
28.
go back to reference Singlas E. Clinical pharmacokinetics of azithromycin. Pathol Biol (Paris). 1995;43(6):505–11.PubMed Singlas E. Clinical pharmacokinetics of azithromycin. Pathol Biol (Paris). 1995;43(6):505–11.PubMed
29.
go back to reference Butranova OI, Ushkalova EA, Zyryanov SK, Chenkurov MS, Baybulatova EA. Pharmacokinetics of antibacterial agents in the elderly: the body of evidence. Biomedicines. 2023;11(6):1633.PubMedPubMedCentralCrossRef Butranova OI, Ushkalova EA, Zyryanov SK, Chenkurov MS, Baybulatova EA. Pharmacokinetics of antibacterial agents in the elderly: the body of evidence. Biomedicines. 2023;11(6):1633.PubMedPubMedCentralCrossRef
31.
go back to reference Crellin E, Mansfield KE, Leyrat C, Nitsch D, Douglas IJ, Root A, et al. Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study. BMJ. 2018;360: k341.PubMedPubMedCentralCrossRef Crellin E, Mansfield KE, Leyrat C, Nitsch D, Douglas IJ, Root A, et al. Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study. BMJ. 2018;360: k341.PubMedPubMedCentralCrossRef
32.
go back to reference Fraser TN, Avellaneda AA, Graviss EA, Musher DM. Acute kidney injury associated with trimethoprim/sulfamethoxazole. J Antimicrob Chemother. 2012;67(5):1271–7.PubMedCrossRef Fraser TN, Avellaneda AA, Graviss EA, Musher DM. Acute kidney injury associated with trimethoprim/sulfamethoxazole. J Antimicrob Chemother. 2012;67(5):1271–7.PubMedCrossRef
33.
go back to reference Rajput J, Moore LSP, Mughal N, Hughes S. Evaluating the risk of hyperkalaemia and acute kidney injury with cotrimoxazole: a retrospective observational study. Clin Microbiol Infect. 2020;26(12):1651–7.PubMedCrossRef Rajput J, Moore LSP, Mughal N, Hughes S. Evaluating the risk of hyperkalaemia and acute kidney injury with cotrimoxazole: a retrospective observational study. Clin Microbiol Infect. 2020;26(12):1651–7.PubMedCrossRef
34.
go back to reference Gentry CA, Nguyen AT. An evaluation of hyperkalemia and serum creatinine elevation associated with different dosage levels of outpatient trimethoprim-sulfamethoxazole with and without concomitant medications. Ann Pharmacother. 2013;47(12):1618–26.PubMedCrossRef Gentry CA, Nguyen AT. An evaluation of hyperkalemia and serum creatinine elevation associated with different dosage levels of outpatient trimethoprim-sulfamethoxazole with and without concomitant medications. Ann Pharmacother. 2013;47(12):1618–26.PubMedCrossRef
35.
go back to reference Downes KJ, Hayes M, Fitzgerald JC, Pais GM, Liu J, Zane NR, et al. Mechanisms of antimicrobial-induced nephrotoxicity in children. J Antimicrob Chemother. 2020;75(1):1–13.PubMedCrossRef Downes KJ, Hayes M, Fitzgerald JC, Pais GM, Liu J, Zane NR, et al. Mechanisms of antimicrobial-induced nephrotoxicity in children. J Antimicrob Chemother. 2020;75(1):1–13.PubMedCrossRef
36.
go back to reference Rudra T, Webb DB, Evans AG. Acute tubular necrosis following co-trimoxazole therapy. Nephron. 1989;53(1):85–6.PubMedCrossRef Rudra T, Webb DB, Evans AG. Acute tubular necrosis following co-trimoxazole therapy. Nephron. 1989;53(1):85–6.PubMedCrossRef
37.
go back to reference Morales-Alvarez MC. Nephrotoxicity of antimicrobials and antibiotics. Adv Chronic Kidney Dis. 2020;27(1):31–7.PubMedCrossRef Morales-Alvarez MC. Nephrotoxicity of antimicrobials and antibiotics. Adv Chronic Kidney Dis. 2020;27(1):31–7.PubMedCrossRef
38.
go back to reference Bird ST, Etminan M, Brophy JM, Hartzema AG, Delaney JA. Risk of acute kidney injury associated with the use of fluoroquinolones. CMAJ. 2013;185(10):E475–82.PubMedPubMedCentralCrossRef Bird ST, Etminan M, Brophy JM, Hartzema AG, Delaney JA. Risk of acute kidney injury associated with the use of fluoroquinolones. CMAJ. 2013;185(10):E475–82.PubMedPubMedCentralCrossRef
39.
go back to reference Sedlacek M, Suriawinata AA, Schoolwerth A, Remillard BD. Ciprofloxacin crystal nephropathy—a ‘new’cause of acute renal failure. Nephrol Dial Transplant. 2006;21(8):2339–40.PubMedCrossRef Sedlacek M, Suriawinata AA, Schoolwerth A, Remillard BD. Ciprofloxacin crystal nephropathy—a ‘new’cause of acute renal failure. Nephrol Dial Transplant. 2006;21(8):2339–40.PubMedCrossRef
40.
go back to reference Shah P, Chock M, Nishimura Y, Say C, Teehera K, Hayashi R, et al. Ciprofloxacin-induced crystal nephropathy and allergic interstitial nephritis: case report and review of literature. Ann Internal Med. 2022;1(5): e220243. Shah P, Chock M, Nishimura Y, Say C, Teehera K, Hayashi R, et al. Ciprofloxacin-induced crystal nephropathy and allergic interstitial nephritis: case report and review of literature. Ann Internal Med. 2022;1(5): e220243.
41.
go back to reference Goli R, Mukku K, Raju S, Uppin M. Acute ciprofloxacin-induced crystal nephropathy with granulomatous interstitial nephritis. Indian J Nephrol. 2017;27(3):231.PubMedPubMedCentralCrossRef Goli R, Mukku K, Raju S, Uppin M. Acute ciprofloxacin-induced crystal nephropathy with granulomatous interstitial nephritis. Indian J Nephrol. 2017;27(3):231.PubMedPubMedCentralCrossRef
42.
go back to reference Hwang YJ, Shariff SZ, Gandhi S, Wald R, Clark E, Fleet JL, et al. Validity of the International Classification of Diseases, Tenth Revision code for acute kidney injury in elderly patients at presentation to the emergency department and at hospital admission. BMJ Open. 2012;2(6):e001821.PubMedPubMedCentralCrossRef Hwang YJ, Shariff SZ, Gandhi S, Wald R, Clark E, Fleet JL, et al. Validity of the International Classification of Diseases, Tenth Revision code for acute kidney injury in elderly patients at presentation to the emergency department and at hospital admission. BMJ Open. 2012;2(6):e001821.PubMedPubMedCentralCrossRef
43.
go back to reference Logan R, Davey P, De Souza N, Baird D, Guthrie B, Bell S. Assessing the accuracy of ICD-10 coding for measuring rates of and mortality from acute kidney injury and the impact of electronic alerts: an observational cohort study. Clin Kidney J. 2020;13(6):1083–90.PubMedCrossRef Logan R, Davey P, De Souza N, Baird D, Guthrie B, Bell S. Assessing the accuracy of ICD-10 coding for measuring rates of and mortality from acute kidney injury and the impact of electronic alerts: an observational cohort study. Clin Kidney J. 2020;13(6):1083–90.PubMedCrossRef
45.
Metadata
Title
Antibiotic-Associated Acute Kidney Injury Among Older Adults: A Case-Crossover Study
Authors
Tichawona Chinzowu
Te-yuan Chyou
Prasad S. Nishtala
Publication date
03-01-2024
Publisher
Springer International Publishing
Published in
Clinical Drug Investigation / Issue 2/2024
Print ISSN: 1173-2563
Electronic ISSN: 1179-1918
DOI
https://doi.org/10.1007/s40261-023-01339-7